Chondroitinases and Chondroitin Lyases

All categories
DBCAT002907Pharmacologic class

Enzymes which catalyze the elimination of glucuronate residues from chondroitin A,B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. EC 4.2.2.-. A DrugBank category of 2 drugs. 2 of them are approved.

Also known as
Chondroitin 4 Sulfate Depolymerase · Chondroitin-4-Sulfate Depolymerase · Chondroitinases · Depolymerase, Chondroitin-4-Sulfate
Drugs

What you can answer from here — as of November 01, 2016

2DrugsEach linked to its full drug card
Listed above
3Drug targetsEvery drug–target pair in the class, with bond type
Sign in
14Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Chondroitinases and Chondroitin Lyases share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In